Pharmacology of doping agents—mechanisms promoting muscle hypertrophy
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Doping with performance enhancing substances in professional andamateur sports has increasingly gained awareness. Furthermore, not only thenumber but also the variety of substances detected in sports has increased.Intending muscle growth, anabolic androgenic steroids (AAS) have beencomplemented by selective androgen receptor modulators (SARMs), β2-adrenergicagonists, estrogen receptor (ER) β agonists and peptide-hormones like growthhormone (GH), insulin-like growth factor-1 (IGF-1) and insulin. However, withrespect to therapeutic use, drugs which increase anabolic actions in the bodyare highly desired for treatment of cachexia, sarcopenia, etc. The aim of the following review is to elaborate on the agents’similarities and differences in mechanisms inducing muscle hypertrophy whilegiving an overview of the relevant signalling cascades. In addition to that,potential agents for treatment of catabolic diseases are identified.Information, onwhich this paper is based on, hasbeen collected from various publications which have been published inhigh-quality scientific journals. The insight obtained has shown that signalling pathways mediatinggenomic actions of steroids have already been well-characterised, while thereis still need for further research on the mechanisms of non-genomicactions and downstream pathways as well as on those of SARMs and β2-adrenergicagonists’ action. A new and promising target is the estrogen receptor β. Theuse of ER-β agonists, which are proposed to activate anabolic mechanismsindependently from androgen receptor activation, may prevent the non-desiredandrogenic effects, which are associated with AAS administration. Thus, theymay be considered a promising alternative for treatment of diseases, whichcause loss of muscle mass and cachexia. In this context, phytoecdysteroids,such as ecdysterone etc, are considered as an interesting class of substances,where further investigations are highly desired. Furthermore, some peptidehormones also promote muscle hypertrophy. The signalling mechanisms of growthhormone, IGF-1 and insulin are summarised. Finally, the potential of myostatininhibition is discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men
Bhasin, S., Storer, T. W., Berman, N., Callegari, C., Clevenger, B., Phillips, J., Bunnell, T. J., Tricker, R., Shirazi, A., & Casaburi, R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607043350101 · Cited by 1,659
Myostatin Mutation Associated with Gross Muscle Hypertrophy in a Child
Schuelke, M., Wagner, K. R., Stolz, L. E., Hübner, C., Riebel, T., Kömen, W., Braun, T., Tobin, J. F., & Lee, S.-J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040933 · Cited by 1,399
Musarò, A., McCullagh, K., Paul, A., Houghton, L., Dobrowolny, G., Molinaro, M., Barton, E. R., L Sweeney, H., & Rosenthal, N. (2001) · Nature Genetics · doi:10.1038/84839 · Cited by 1,137
Skeletal muscle hypertrophy and atrophy signaling pathways
Glass, D. J. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.04.018 · Cited by 1,106 · cited 3×
“Evidence is increasing that MuRF1 and MAFbx play a key role in muscle atrophy [35,126,131].”
BackgroundMyostatin, a Negative Regulator of Muscle Growth, Functions by Inhibiting Myoblast Proliferation
Thomas, M., Langley, B., Berry, C., Sharma, M., Kirk, S., Bass, J., & Kambadur, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004356200 · Cited by 1,014
Androgen Receptor (AR) Coregulators: An Overview
Heinlein, C. A., & Chang, C. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0460 · Cited by 943
Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k
Jefferies, H. B. J., Fumagalli, S., Dennis, P. B., Reinhard, C., Pearson, R. B., & Thomas, G. (1997) · The EMBO Journal · doi:10.1093/emboj/16.12.3693 · Cited by 934
Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators
Smith, C. L., & O’Malley, B. W. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0023 · Cited by 931
Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models
Schiaffino, S., & Mammucari, C. (2011) · Skeletal Muscle · doi:10.1186/2044-5040-1-4 · Cited by 816
Signalling pathways that mediate skeletal muscle hypertrophy and atrophy
Glass, D. J. (2003) · Nature Cell Biology · doi:10.1038/ncb0203-87 · Cited by 694
Pathogenesis of insulin resistance in skeletal muscle
Abdul-Ghani, M. A., & DeFronzo, R. A. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/476279 · Cited by 670 · cited 1×
“Additionally, muscle wasting is associated with an increased risk of developing metabolic diseases, such as metabolic syndrome or type-2 diabetes [85].”
BackgroundGonzalez-Cadavid, N. F., Taylor, W. E., Yarasheski, K., Sinha-Hikim, I., Ma, K., Ezzat, S., Shen, R., Lalani, R., Asa, S., Mamita, M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14938 · Cited by 571 · cited 1×
“Upregulation of myostatin results in muscle atrophy [65], which is also reported as effect after glucocorticoid administration or neuron-derived orphan”
BackgroundSteroid-hormone rapid actions, membrane receptors and a conformational ensemble model
Norman, A. W., Mizwicki, M. T., & Norman, D. P. G. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1283 · Cited by 569
Nongenomic steroid action: controversies, questions, and answers
LÖSEL, R. M., FALKENSTEIN, E., FEURING, M., SCHULTZ, A., TILLMANN, H.-C., ROSSOL-HASEROTH, K., & WEHLING, M. (2003) · Physiological Reviews · doi:10.1152/physrev.00003.2003 · Cited by 561 · cited 1×
“Last but not least, sex hormone binding globulin receptors (SHBGR) have been proposed to also use the AC-PKA-signalling pathway in order to modulate target gene transcription [9,12,14,15].”
BackgroundSmad2 and 3 transcription factors control muscle mass in adulthood
Sartori, R., Milan, G., Patron, M., Mammucari, C., Blaauw, B., Abraham, R., & Sandri, M. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00104.2009 · Cited by 517
Non-genomic actions of androgens
Foradori, C. D., Weiser, M. J., & Handa, R. J. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2007.10.005 · Cited by 493 · cited 12×
“Keywords: muscle hypertrophy; performance enhancement; signalling cascades; doping agents; anabolic-androgenic steroids; beta-2-adrenergic agonists; peptide hormones Abbreviations: 4E-BP1: 4E binding protein-1; AAS: anabolic androgenic steroids; AC: adenylylcyclases; ActRIIB: activin type IIB receptor; ALK4/5: activin…”
BackgroundInfluentialThe human glucocorticoid receptor: molecular basis of biologic function
Nicolaides, N. C., Galata, Z., Kino, T., Chrousos, G. P., & Charmandari, E. (2010) · Steroids · doi:10.1016/j.steroids.2009.09.002 · Cited by 436 · cited 1×
“They are considered as most important stress hormones in mammals (including humans) besides adrenaline and noradrenaline [17].”
BackgroundDobs, A. S., Boccia, R. V., Croot, C. C., Gabrail, N. Y., Dalton, J. T., Hancock, M. L., Johnston, M. A., & Steiner, M. S. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70055-x · Cited by 391
Signaling pathways perturbing muscle mass.
Glass, D. J. (2010) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32833862df · Cited by 359
Molecular cell biology of androgen receptor signalling
Bennett, N. C., Gardiner, R. A., Hooper, J. D., Johnson, D. W., & Gobe, G. C. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.11.013 · Cited by 292 · cited 13×
“Keywords: muscle hypertrophy; performance enhancement; signalling cascades; doping agents; anabolic-androgenic steroids; beta-2-adrenergic agonists; peptide hormones Abbreviations: 4E-BP1: 4E binding protein-1; AAS: anabolic androgenic steroids; AC: adenylylcyclases; ActRIIB: activin type IIB receptor; ALK4/5: activin…”
BackgroundInfluentialDevelopment of selective androgen receptor modulators (SARMs)
Narayanan, R., Coss, C. C., & Dalton, J. T. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.06.013 · Cited by 251 · cited 4×
“The exact mechanism of their tissue selectivity still remains uncovered until now [39].”
BackgroundInfluentialThe bone morphogenetic protein axis is a positive regulator of skeletal muscle mass
Winbanks, C. E., Chen, J. L., Qian, H., Liu, Y., Bernardo, B. C., Beyer, C., Watt, K. I., Thomson, R. E., Connor, T., Turner, B. J., et al. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201211134 · Cited by 225
Winbanks, C. E., Weeks, K. L., Thomson, R. E., Sepulveda, P. V., Beyer, C., Qian, H., Chen, J. L., Allen, J. M., Lancaster, G. I., Febbraio, M. A., et al. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201109091 · Cited by 218
The myokine decorin is regulated by contraction and involved in muscle hypertrophy
Kanzleiter, T., Rath, M., Görgens, S. W., Jensen, J., Tangen, D. S., Kolnes, A. J., Kolnes, K. J., Lee, S., Eckel, J., Schürmann, A., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.06.123 · Cited by 209
Christou, M. A., Christou, P. A., Markozannes, G., Tsatsoulis, A., Mastorakos, G., & Tigas, S. (2017) · Sports Medicine · doi:10.1007/s40279-017-0709-z · Cited by 199 · cited 1×
“Alterations of sexual function and infertility is also associated with the administration of AAS [29,30].”
BackgroundWatkins, L. E., Jones, D. J., Mowrey, D. H., Anderson, D. B., & Veenhuizen, E. L. (1990) · Journal of Animal Science · doi:10.2527/1990.68113588x · Cited by 198
Myostatin and Sarcopenia: Opportunities and Challenges - A Mini-Review
White, T. A., & LeBrasseur, N. K. (2014) · Gerontology · doi:10.1159/000356740 · Cited by 191
Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol
Kline, W. O., Panaro, F. J., Yang, H., & Bodine, S. C. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00873.2006 · Cited by 177
Phytoecdysteroids increase protein synthesis in skeletal muscle cells.
Gorelick-Feldman, J., MacLean, D., Ilic, N., Poulev, A., Lila, M. A., Cheng, D., & Raskin, I. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf073059z · Cited by 166 · cited 3×
“Overall, resulting effects in muscle cells include increased protein synthesis, promotion of IGF-1 synthesis, increased insulin sensitivity, expanded apoptosis, and improved utilisation of glucose and lipids, while reducing protein degradation [21,33,34,37].”
BackgroundSelective estrogen receptor-β activation stimulates skeletal muscle growth and regeneration
Velders, M., Schleipen, B., Fritzemeier, K. H., Zierau, O., & Diel, P. (2012) · The FASEB Journal · doi:10.1096/fj.11-194779 · Cited by 162
Signaling pathways weigh in on decisions to make or break skeletal muscle
Guttridge, D. C. (2004) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/01.mco.0000134364.61406.26 · Cited by 149 · cited 4×
“Activated p70 also promotes protein synthesis while PHAS-1/4E-BP1 is supposed to mediate translation initiation after release of the translation initiation factor elF4E [56,130].”
BackgroundInfluentialWeiser, M. J., Wu, T. J., & Handa, R. J. (2009) · Endocrinology · doi:10.1210/en.2008-1355 · Cited by 124
MacLennan, P. A., & Edwards, R. H. (1989) · Biochemical Journal · doi:10.1042/bj2640573 · Cited by 119
Parr, M. K., Zhao, P., Haupt, O., Ngueu, S. T., Hengevoss, J., Fritzemeier, K. H., Piechotta, M., Schlörer, N., Muhn, P., Zheng, W., et al. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300806 · Cited by 106 · cited 5×
“Ecdysterone is reported to influence adipose and muscle tissue, resulting in increased muscle mass and body weight while decreasing visceral fat mass [33,37,122].”
BackgroundInfluentialSelf-citationEcdysteroids: A novel class of anabolic agents?
Parr, M., Botrè, F., Naß, A., Hengevoss, J., Diel, P., & Wolber, G. (2014) · Biology of Sport · doi:10.5604/20831862.1144420 · Cited by 95 · cited 2×
“Furthermore, in a recent study, same doses of the phytoecdysteroid ecdysterone elicited stronger hypertrophic effects in mouse myoblastoma cell line C2C12 derived myotubes than the AAS metandienone, estradienedione and SARM S1 [122].”
BackgroundSelf-citationApigenin Enhances Skeletal Muscle Hypertrophy and Myoblast Differentiation by Regulating Prmt7
Jang, Y. J., Son, H. J., Choi, Y. M., Ahn, J., Jung, C. H., & Ha, T. Y. (2017) · Oncotarget · doi:10.18632/oncotarget.20962 · Cited by 59
Weigt, C., Hertrampf, T., Zoth, N., Fritzemeier, K. H., & Diel, P. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.12.013 · Cited by 56 · cited 4×
“Overall, resulting effects in muscle cells include increased protein synthesis, promotion of IGF-1 synthesis, increased insulin sensitivity, expanded apoptosis, and improved utilisation of glucose and lipids, while reducing protein degradation [21,33,34,37].”
BackgroundInfluential
Cited by
McCullough, D., Webb, R., Enright, K. J., Lane, K. E., McVeigh, J., Stewart, C. E., & Davies, I. G. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09616-y · Cited by 62
“Genomic actions of AAS occur when androgens bind to the nuclear androgen receptor (AR) and translocate to the cell nucleus, binding to specific DNA sequences resulting in enhanced transcription of target anabolic genes [17, 18].”
BackgroundInfluential20-Hydroxyecdysone activates the protective arm of the RAAS via the MAS receptor
Lafont, R., Serova, M., Didry-Barca, B., Raynal, S., Guibout, L., Dinan, L., Veillet, S., Latil, M., Dioh, W., & Dilda, P. J. (2022) · Journal of Molecular Endocrinology · doi:10.1530/jme-21-0033 · Cited by 50
Targeting the administration of ecdysterone in doping control samples
Parr, M. K., Ambrosio, G., Wuest, B., Mazzarino, M., de la Torre, X., Sibilia, F., Joseph, J. F., Diel, P., & Botrè, F. (2020) · Forensic Toxicology · doi:10.1007/s11419-019-00504-y · Cited by 38
Self-citationAmbrosio, G., Yuliandra, T., Wuest, B., Mazzarino, M., Torre, X. D. L., Botrè, F., Diel, P., Isenmann, E., & Parr, M. K. (2021) · doi:10.20944/preprints202105.0106.v1 · Cited by 14
Self-citation20-Hydroxyecdysone activates the protective arm of the renin angiotensin system via Mas receptor
Lafont, R., Raynal, S., Serova, M., Didry-Barca, B., Guibout, L., Latil, M., Dilda, P. J., Dioh, W., & Veillet, S. (2020) · doi:10.1101/2020.04.08.032607 · Cited by 11
Metadata
- Authors
- Kristina Parr, M., Pharmaceutical and Medicinal Chemistry, I. O. P., & Müller-Schöll, A.
- Venue
- AIMS Molecular Science
- Published
- 2018
- Volume
- 5
- Issue
- 2
- Pages
- 145-155
- ISSN
- 2372-028X (ISSN-L)
- 2372-0301
- OpenAlex
- W2797051188
- Cited by
- 15
- References
- 37
- FWCI
- 3.42
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.